Risk Factors of Graft Survival After Diagnosis of Post-kidney Transplant Malignancy: Using Cox Proportional Hazard Model

Authors Information
Article Notes and Dates
To Cite : Rahimi Foroushani A, Salesi M, Rostami Z, Mehrazmay A R, Mohammadi J, et al. Risk Factors of Graft Survival After Diagnosis of Post-kidney Transplant Malignancy: Using Cox Proportional Hazard Model, Iran Red Crescent Med J. 2015 ;17(11):e20281. doi: 10.5812/ircmj.20281.
Copyright: Copyright © 2015, Iranian Red Crescent Medical Journal. .
Abstract
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Navarro MD, Lopez-Andreu M, Rodriguez-Benot A, Aguera ML, Del Castillo D, Aljama P. Cancer incidence and survival in kidney transplant patients. Transplant Proc. 2008; 40(9): 2936-40[DOI][PubMed]
  • 2. Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet. 2000; 355(9218): 1886-7[DOI]
  • 3. Peto J. Nature. 2001; 411(6835): 390-5[DOI]
  • 4. Penn I. Malignancies associated with renal transplantation. Urology. 1977; 10: 57–63
  • 5. Penn I. Second malignant neoplasms associated with immunosuppressive medications. Cancer. 1976; 37(2 Suppl): 1024-32[PubMed]
  • 6. Ojo AO, Hanson JA, Wolfe RA, Leichtman AB, Agodoa LY, Port FK. Long-term survival in renal transplant recipients with graft function. Kidney Int. 2000; 57(1): 307-13[DOI]
  • 7. Penn I. Cancers in renal transplant recipients. Adv Ren Replace Ther. 2000; 7(2): 147-56[PubMed]
  • 8. Zeier M, Hartschuh W, Wiesel M, Lehnert T, Ritz E. Malignancy after renal transplantation. Am J Kidney Dis. 2002; 39(1)[DOI][PubMed]
  • 9. Iranian network for organ procurement. . 2009;
  • 10. Rezaei M, Kazemnejad A, Bardideh A. R. , Mahmoudi M. Factors Affecting Survival in Kidney Recipients at Kermanshah. Urol J. 2004; 1(3): 180-7
  • 11. Braun WE, Yadlapalli NG. The spectrum of long-term renal transplantation: Outcomes, complications, and clinical studies. Transplant Rev. 2002; 16(1): 22-50[DOI]
  • 12. Mazuecos A, Muñoz Terol JM, García Alvárez T, Sola E, Rodríguez Benot A, Dsuna A, et al. Increase in Malignancies as Cause of Death in Renal Transplant Patients. Transplant Proceedings. 2009; 41(6): 2159-62[DOI]
  • 13. Tiong HY, Goldfarb DA, Kattan MW, Alster JM, Thuita L, Yu C, et al. Nomograms for Predicting Graft Function and Survival in Living Donor Kidney Transplantation Based on the UNOS Registry. J Urol. 2009; 181(3): 1248-55[DOI]
  • 14. Harada KM, Mandia-Sampaio EL, de Sandes-Freitas TV, Felipe CR, Park SI, Pinheiro-Machado PG, et al. Risk Factors Associated With Graft Loss and Patient Survival After Kidney Transplantation. Transplantation Proceedings. 2009; 41(9): 3667-70[DOI]
  • 15. Harada KM, Mandia-Sampaio EL, de Sandes-Freitas TV, Felipe CR, Park SI, Pinheiro-Machado PG, et al. Risk factors associated with graft loss and patient survival after kidney transplantation. Transplant Proc. 2009; 41(9): 3667-70[DOI][PubMed]
  • 16. Rao PS, Schaubel DE, Jia X, Li S, Port FK, Saran R. Survival on Dialysis Post–Kidney Transplant Failure: Results From the Scientific Registry of Transplant Recipients. American Journal of Kidney Diseases. 2007; 49(2): 294-300[DOI]
  • 17. Errasti P, Manrique J, Lavilla J, Rossich E, Hernandez A, Pujante D, et al. Autosomal-dominant polycystic kidney disease: high prevalence of graft loss for death-related malignancies and cardiovascular risk factors. Transplant Proceedings. 2003; 35(5): 1717-9[DOI]
  • 18. Braun WE. Comprehensive Clinical Nephrology. 2003; : 1105-23
  • 19. Braun WE. Cardiovascular and Other Noninfectious Complications after Renal Transplantation in Adults. 2008; : 1009-33[DOI]
  • 20. Norman DJ. Primer on Transplantation. 2001;
  • 21. Einollahi B, Rostami Z, Nourbala MH, Lessan-Pezeshki M, Simforoosh N, Nemati E, et al. Incidence of malignancy after living kidney transplantation: a multicenter study from iran. J Cancer. 2012; 3: 246-56[DOI][PubMed]
  • 22. Dantal J, Pohanka E. Malignancies in renal transplantation: an unmet medical need. Nephrol Dial Transplant. 2007; 22 Suppl 1-10[DOI][PubMed]
  • 23. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved Graft Survival after Renal Transplantation in the United States, 1988 to 1996. N England J Med. 2000; 342(9): 605-12[DOI]
  • 24. Cecka JM. The OPTN/UNOS Renal Transplant Registry. Clin Transpl. 2005; : 1-16[PubMed]
  • 25. Vanhove T, Kuypers D, Claes KJ, Evenepoel P, Meijers B, Naesens M, et al. Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome. Transpl Int. 2013; 26(8): 813-21[DOI][PubMed]
  • 26. Briganti EM. Graft loss following renal transplantation in Australia: is there a centre effect? Nephrol Dialysis Transplant. 2002; 17(6): 1099-104[DOI]
  • 27. Wigmore SJ, Seeney FM, Pleass HC, Praseedom RK, Forsythe JL. Kidney damage during organ retrieval: data from UK National Transplant Database. Lancet. 1999; 354(9185): 1143-6[DOI]
  • 28. Saudan P, Berney T, Leski M, Morel P, Bolle JF, Martin PY. Renal transplantation in the elderly: a long-term, single-centre experience. Nephrol Dial Transplant. 2001; 16(4): 824-8[PubMed]
  • 29. Kolonko A, Chudek J, Wiecek A. Nephron Underdosing as a Risk Factor for Impaired Early Kidney Graft Function and Increased Graft Loss During the Long-Term Follow-up Period. Transplant Proceedings. 2013; 45(4): 1639-43[DOI]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Iranian Red Crescent Medical Journal accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check